CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

NCT00257205 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

655

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: dacarbazine
DRUG: CP-675,206
DRUG: temozolomide

Sponsor

AstraZeneca